Author: News Room

LONDON, Nov. 27, 2023 (GLOBE NEWSWIRE) — Momcozy, a leading brand for maternal care products, celebrates the successful wrap-up of its ‘Stand Up For Mums’ campaign. This impactful initiative included a lively stand-up comedy event held in London on November 19 and a significant online movement to honour and amplify the voices of mothers. Engaging around 8,000 mothers across the UK, the campaign highlights Momcozy’s unwavering commitment to supporting and celebrating the essence of motherhood. The Stand-Up Comedy Show: A Tribute to Mothers and Mothers-To-BeOn November 19, 2023, Momcozy organized Stand Up For Mums — a special stand-up comedy show…

Read More

Exa automates manual tasks to help enhance staff productivity, expedite patient care and maximize revenue WAYNE, N.J., Nov. 26, 2023 (GLOBE NEWSWIRE) — Approximately half of recommended patient follow-up contained in radiology reports, including incidental findings, are not acted upon and often result in missed or delayed diagnosis.1,2 Automating this process has been shown to increase patient follow-up rates, which may improve patient outcomes as well as increase adherence to additional follow-up recommendations by up to 60%.3 To address this need, Konica Minolta Healthcare introduces Exa Connect as part of the Exa® Platform. Using artificial intelligence to efficiently identify patients…

Read More

If you purchased or acquired securities in DocGo between November 8, 2022 and September 17, 2023 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310). You may also click here for additional information: www.faruqilaw.com/DCGO. There is no cost or obligation to you. NEW YORK, Nov. 26, 2023 (GLOBE NEWSWIRE) — Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against DocGo Inc. (“DocGo” or the “Company”) (NASDAQ: DCGO) and reminds investors of the December 26, 2023 deadline to seek the role of…

Read More

If you purchased or acquired securities in Outlook between December 29, 2022 and August 29, 2023 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310). You may also click here for additional information: www.faruqilaw.com/OTLK. There is no cost or obligation to you. NEW YORK, Nov. 26, 2023 (GLOBE NEWSWIRE) — Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Outlook Therapeutics, Inc. (“Outlook” or the “Company”) (NASDAQ: OTLK) and reminds investors of the January 2, 2024 deadline to seek the role…

Read More

If you purchased or acquired securities in Farfetch between March 9, 2023 and August 17, 2023 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310). You may also click here for additional information: www.faruqilaw.com/FTCH. There is no cost or obligation to you. NEW YORK, Nov. 26, 2023 (GLOBE NEWSWIRE) — Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Farfetch Limited (“Farfetch” or the “Company”) (NYSE: FTCH) and reminds investors of the December 19, 2023 deadline to seek the role of…

Read More

If you purchased or acquired securities in DLocal stock or options between May 2, 2022 and May 25, 2023 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310). You may also click here for additional information: www.faruqilaw.com/DLO. There is no cost or obligation to you. NEW YORK, Nov. 26, 2023 (GLOBE NEWSWIRE) — Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against DLocal Limited (“DLocal” or the “Company”) (NASDAQ: DLO) and reminds investors of the December 5, 2023 deadline to seek…

Read More

If you purchased or acquired securities in Beauty Health between May 10, 2022 and November 13, 2023 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310). You may also click here for additional information: www.faruqilaw.com/SKIN. There is no cost or obligation to you. NEW YORK, Nov. 26, 2023 (GLOBE NEWSWIRE) — Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against The Beauty Health Company (“Beauty Health” or the “Company”) (NASDAQ: SKIN) and reminds investors of the January 16, 2024 deadline to…

Read More

If you purchased or acquired (i) GigaCloud Class A ordinary shares pursuant and/or traceable to the registration statement and prospectus issued in connection with the Company’s August 2022 initial public offering (“IPO” or the “Offering”); and/or (ii) GigaCloud securities between August 18, 2022 and September 27, 2023, and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310). You may also click here for additional information: www.faruqilaw.com/GCT. There is no cost or obligation to you. NEW YORK, Nov. 26, 2023 (GLOBE NEWSWIRE) — Faruqi & Faruqi, LLP, a leading…

Read More

If you purchased or acquired securities in Illumina between May 1, 2023 and October 16, 2023 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310). You may also click here for additional information: www.faruqilaw.com/ILMN. There is no cost or obligation to you. NEW YORK, Nov. 26, 2023 (GLOBE NEWSWIRE) — Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Illumina, Inc. (“Illumina” or the “Company”) (NASDAQ: ILMN) and reminds investors of the January 9, 2024 deadline to seek the role of…

Read More

If you purchased or acquired securities in SC Health Corporation (“SC Health”) (NYSE: SCPE; NYSE: SCPE.WS; NYSE: SCPE.U) and Rockley Photonics Holdings Limited (“Rockley”) (NYSE: RKLY; NYSE: RKLY.WS) securities between March 19, 2021 and January 23, 2023, inclusive (the “Class Period”) and purchasers directly in the March 2021 private investment in public equity of Rockley shares (the “PIPE Offering”) conducted in connection with the merger of SC Health and Rockley (the “Merger”) and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310). You may also click here for…

Read More